The Medicines and Health products Regulatory Agency (MHRA) met with stakeholders to begin to develop guidance on human factors to promote patient safety.
The guidance will be mainly aimed at the medical devices industry, although could be useful for clinicians, procurement specialists and professionals with an interest in patient safety.
The group includes representatives from notified bodies, academia, NICE, trade bodies and professional associations as well as representatives from the devices, licensing and vigilance and risk management in medicines divisions at MHRA. Dr Brian Edwards of the Clinical Human Factors Group gave a stimulating presentation saying:
“It’s important to work together in particular areas where we have overlapping interests such as drug/ device combinations.”